Loading live market data…

HeartBeam, Inc.

NASDAQ:BEAT

$0.5652 USD

$0.0 (0.78%)

Volume
67.26K
Average Volume
967.45K
Market Capitalization
$19.47M
P/E Ratio
-0.99
Dividend Yield
0.00%
Price Target
$2.00
Year High
$4.00
Year Low
$0.51
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.74

Industry, Sector & symbol

Stock Exchange NASDAQ
CEO Robert Eno
Industry Medical - Equipment & Services
Sector Healthcare
Current Symbol BEAT
CUSIP 42238H108
CIK 0001779372
Web https://www.heartbeam.com
Phone 408 899 4443
Currency USD
Employees 16
Country US

Liquidity

Debt-to-Equity Ratio 0.00
Payout Ratio 0.00
Current Ratio 0.74
Quick Ratio 0.70
Cash Ratio 0.62

Sales & Book Value

Annual Sales $-
Price / Sales 0.00
Cash Flow -0.34
Price / Cash Flow -1.39
Price / Book 36.13

Price Target and Rating

Average Stock Price Forecast $2.00
High Stock Price Forecast $2.00
Low Stock Price Forecast $2.00
Forecast Upside/Downside -71.74%
Consensus Rating Strong Sell
Rating Score(0-5) 1
Research Coverage 13 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.62
Trailing P/E Ratio -0.99
PEG Ratio -0.04
P/E Growth -0.04
Net Income $-21.02M
Net Margin 0.00%
Pretax Margin 0.00%
Return on Equity -1034.04%
Return on Assets -514.91%

Financials Score

AltmanZ Score -42.78
Piotroski Score 1.00
Working Capital -859K
Total Assets 3.93M
Ebit -20.23M
Market Cap 20.23M
Total Liabilities 3.29M

Poll Results

About HeartBeam, Inc. (NASDAQ:BEAT) Stock

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA. ...

HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device

2026-07-14 08:00:00

[url="]HeartBeam, Inc.[/url] (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today an

Bet On These 5 Top-Ranked Stocks With Increasing P/E Ratios

2026-07-07 10:31:24

Tap these five stocks, W, DHR, ISRG, BEAT and CSW, with rising P/E ratios to try out an out-of-the-box approach.

HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule

2026-06-30 07:00:00

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule.

HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

2026-06-24 16:05:00

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition.

HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home

2026-06-02 08:00:00

[url="]HeartBeam, Inc.[/url] (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today an

HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home

2026-06-02 07:00:00

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home.

HeartBeam (BEAT) Upgraded to Buy: Here's What You Should Know

2026-05-27 13:01:19

HeartBeam (BEAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

HeartBeam Reports First Quarter 2026 Results

2026-05-13 16:01:00

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports First Quarter 2026 Results.

Frequently Asked Questions

What is the current HeartBeam, Inc. (BEAT) stock price?

HeartBeam, Inc.(NASDAQ:BEAT) stock price is $0.5652 in the last trading session. During the trading session, BEAT stock reached the peak price of $4 while $0.508 was the lowest point it dropped to. The percentage change in BEAT stock occurred in the recent session was 0.78% while the dollar amount for the price change in BEAT stock was $0.0.

BEAT's industry and sector of operation?

The NASDAQ listed BEAT is part of Medical - Equipment & Services industry that operates in the broader Healthcare sector.

Who are the executives of BEAT?

Richard Ferrari | Executive Chairman
Robert Eno | Chief Executive Officer, Chief Business Officer & Director
Timothy Cruickshank | Chief Financial Officer
Richa Gujarati | Senior Vice President of Product
Branislav Vajdic | Founder, President & Director

How many employees does BEAT have?

Number of BEAT employees currently stands at 16. BEAT operates from 2118 Walsh Avenue, Santa Clara, CA 95050, US.

Link for BEAT official website?

Official Website of BEAT is: https://www.heartbeam.com

How do I contact BEAT?

BEAT could be contacted at phone #408 899 4443 and can also be accessed through its website. BEAT operates from 2118 Walsh Avenue, Santa Clara, CA 95050, US.

How many shares of BEAT are traded daily?

The average number of BEAT shares traded daily for last 3 months was 967.45K.

What is the market cap of BEAT currently?

The market value of BEAT currently stands at $19.47M with its latest stock price at $0.5652